Effects of a single high dose of cisplatin on the melanocytes of the stria vascularis in the guinea pig

Audiology and Neurotology

Volumn 12, Issue 3, 2007, Pages 170-178

  Laurell, Göran ^a   Ekborn, Andreas ^b   Viberg, Agneta ^b   Canlon, Barbara ^b  

^a UMEÅ UNIVERSITY   (Sweden)

^b KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Auditory brainstem response; Cochlea; Cochleogram; Intermediate cells; Melanin; Multiple cytotoxic effect

Indexed keywords

CISPLATIN; MELANIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; AUDITORY THRESHOLD; COCHLEA; CONTROLLED STUDY; CORRELATION ANALYSIS; DRUG BLOOD LEVEL; DRUG CYTOTOXICITY; DRUG EFFECT; DRUG MEGADOSE; EVOKED BRAIN STEM AUDITORY RESPONSE; FEMALE; FREQUENCY MODULATION; GUINEA PIG; HAIR CELL; MALE; MELANOCYTE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SINGLE DRUG DOSE; STRIA VASCULARIS;

ANIMALS; ANTINEOPLASTIC AGENTS; APOPTOSIS; AUDITORY THRESHOLD; CISPLATIN; EVOKED POTENTIALS, AUDITORY, BRAIN STEM; FEMALE; GUINEA PIGS; HAIR CELLS; INJECTIONS, INTRAVENOUS; MALE; MELANOCYTES; STRIA VASCULARIS;

EID: 34147137757     PISSN: 14203030     EISSN: 14219700     Source Type: Journal    
DOI: 10.1159/000099020     Document Type: Article

References (34)

1. Alam SA, Ikeda K, Oshima T, Suzuki M, Kawase T, Kikuchi T, Takasaka T: Cisplatin-induced apoptotic cell death in Mongolian gerbil cochlea. Hear Res 2000;141:28-38.
2. Araki S, Mizuta K, Takeshita T, Morita H, Mineta H, Hoshino T: Degeneration of the stria vascularis during development in melanocyte-deficient mutant rats (Ws/Ws rats). Eur Arch Otorhinolaryngol 2002;259:309-315.
3. Barr-Hamilton RM, Matheson LM, Keay DG: Ototoxicity of cisplatin and its relationship to eye colour. J Laryngol Otol 1991;105:7-11.
4. Cable J, Barkway C, Steel KP: Characteristics of stria vascularis melanocytes of viable dominant spotting (Wv/Wv) mouse mutants. Hear Res 1992;64:6-20.
5. Campbell KCM, Meech RP, Rybak LP, Hughes LF: D-Methionine protects against cisplatin damage to the stria vascularis. Hear Res 1999;138:13-28.
6. Cardinaal RM, De Groot JC, Huizing EH, Smoorenburg GF, Veldman JE: Ultrastructural changes in the albino guinea pig cochlea at different survival times following cessation of 8-day cisplatin administration. Acta Otolaryngol 2004;124:144-154.
7. Devarajan P, Savoca M, Castaneda MP, Park MS, Esteban-Cruciani N, Kalinec G, Kalinec F: Cisplatin-induced apoptosis in auditory cells: role of death receptor and mitochondrial pathways. Hear Res 2002;174:45-54.
8. Ekborn A, Laurell G, Andersson A, Wallin I, Eksborg S, Ehrsson H: Cisplatin-induced hearing loss: influence of the mode of drug administration in the guinea pig. Hear Res 2000;140:38-44.
9. Furumura M, Solano F, Matsunga N, Sakai C, Spritz RA, Hearing VJ: Metal ligand-binding specificities of the tyrosinase-related proteins. Biochem Biophys Res Commun 1998;242:579-585.
10. Greenwood DD: Comparing octaves, frequency ranges, and cochlear-map curvature across species. Hear Res 1996;94:157-162.
11. Hamers FPT, Wijbenga J, Wolters FLC, Klis SFL, Sluyter S, Smoorenburg GF: Cisplatin ototoxicity involves organ of Corti, stria vascularis and spiral ganglion: modulation by α-MSH and ORG 2766. Audiol Neurootol 2003;8:305-315.
12. Jara JR, Solano F, Garcia-Borron JC, Aroca P, Lozano JA: Regulation of mammalian melanogenesis. II: The role of metal cations. Biochim Biophys Acta 1990;1035:276-285.
13. Klis SFL, O'Leary SJ, Wijbenga J, de Groot JCMJ, Hamers FPT, Smoorenburg GF: Partial recovery of cisplatin-induced hearing loss in the albino guinea pig in relation to cisplatin dose. Hear Res 2002;164:138-146.
14. Komune S, Asakuma A, Snow JB Jr: Pathophysiology of the ototoxicity of cis-diamminedi-chloroplatinum. Otolaryngol Head Neck Surg 1981;89:275-282.
15. Laurell G, Engström B: The ototoxic effect of cisplatin on guinea pigs in relation to dosage. Hear Res 1989;38:27-34.
16. Laurell G, Teixeira M, Sterkers O, Ferrary E: Effect of cisplatin administration on the electrochemical composition of endolymph in the rat cochlea. Hear Res 1995;87:16-20.
17. Lee JE, Nakagawa T, Kita TS, Iguchi F, Endo T, Shiga A, Lee SH, Ito J: Mechanisms of apoptosis induced by cisplatin in marginal cells in mouse stria vascularis. ORL J Otorhinolaryngol Relat Spec 2004;66:111-118.
18. Liu W, Staecker H, Stupak H, Malgrange B, Lefebvre P, Van De Water T: Caspase inhibitors prevent cisplatin-induced apoptosis of auditory sensory cells. Neuroreport 1998;9:2609-2614.
19. Lyttkens L, Larsson B, Goller H, Englesson S, Stahle J: Melanin capacity to accumulate drugs in the internal ear. A study of lidocaine, bupivacaine and chlorpromazine. Acta Otolaryngol 1979;88:61-73.
20. Mars U, Larsson BS: Pheomelanin as a binding site for drugs and chemicals. Pigment Cell Res 1999;12:266-274.
21. Meech RP, Campbell KCM, Hughes LP, Rybak LP: A semiquantitative analysis of the effects of cisplatin on the rat stria vascularis. Hear Res 1998;124:44-59.
22. Ono C, Tanaka M: Binding characteristics of fluoroquinolones to synthetic levodopa melanin. J Pharm Pharmacol 2003;55:1127-1133.
23. Schweitzer VG: Cisplatin-induced ototoxicity: the effect of pigmentation and inhibitory agents. Laryngoscope 1993;103:1-52.
24. Schweitzer VG, Rarey KE, Dolan DF, Abrams G, Litterst CJ, Sheridan C: Ototoxicity of cisplatin vs platinum analogs CBDCA (JM-8) and CHIP (JM-9). Otolaryngol Head Neck Surg 1986;94:458-470.
25. Sluyter S, Klis SFL, de Groot JCMJ, Smoorenburg GF: Alterations in the stria vascularis in relation to cisplatin ototoxicity and recovery. Hear Res 2003;185:49-56.
26. Suzuki M, Kaga K: Effect of cisplatin on the basement membrane anionic sites in the ampulla, macula, and stria vascularis of guinea pigs. Ann Otol Rhinol Laryngol 1997;106:971-975.
27. Svensson SPS, Lindgren S, Powell W, Green H: Melanin inhibits cytotoxic effects of doxyrubicin and daunorubicin in MOLT 4 cells. Pigment Cell Res 2003;16:351-354.
28. Takeuchi S, Ando M, Kakigi A: Mechanism generating endocohlear potential: role played by intermediate cells in stria vascularis. Biophys J 2000;79:2572-2582.
29. Tange RA, Vuzevski VD: Changes in the stria vascularis of the guinea pig due to cis-platinum. Arch Otorhinolaryngol 1984;239:41-47.
30. Thomas JP, Lautermann J, Liedert B, Seiler F, Thomale J: High accumulation of platinum-DNA adducts in strial marginal cells of the cochlea is an early event in cisplatin but not carboplatin ototoxicity. Mol Pharmacol 2006;70:23-29.
31. Tsukasaki N, Whitworth CA, Rybak LP: Acute changes in cochlear potentials due to cisplatin. Hear Res 2000;149:189-198.
32. Van Ruijven MW, de Groot JC, Klis SF, Smoorenburg GF: The cochlear targets of cisplatin: an electrophysiological and morphological time-sequence study. Hear Res 2005;205:241-248.
33. Watanabe K, Inai S, Jinnouchi K, Bada S, Hess A, Michel O, Yagi T: Nuclear-factor kappa B (NF-kappa B)-inducible nitric oxide synthase (iNOS/NOS II) pathway damages the stria vascularis in cisplatin-treated mice. Anticancer Res 2002;22:4081-4085.
34. Wrzesniok D, Surazynski A, Karna E, Buszman E, Palka J: Melanin counter act puromycin-induced inhibition of collagen and DNA biosynthesis in human skin fibroblasts. Life Sci 2005;77:528-538.